Definitive Healthcare (NASDAQ:DH) Updates Q2 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its second quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.08-$0.09 for the period, compared to the consensus EPS estimate of $0.09. The company issued revenue guidance of $62.0-$63.5 million, compared to the consensus revenue estimate of $65.19 million. Definitive Healthcare also updated its FY24 guidance to $0.36-$0.38 EPS.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Morgan Stanley lowered shares of Definitive Healthcare from an overweight rating to an equal weight rating and lowered their target price for the stock from $11.50 to $9.00 in a research note on Wednesday. Needham & Company LLC reiterated a hold rating on shares of Definitive Healthcare in a research report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price target on shares of Definitive Healthcare from $10.00 to $7.00 and set a hold rating for the company in a report on Thursday. Barclays dropped their target price on shares of Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating on the stock in a research report on Thursday. Finally, Stifel Nicolaus decreased their price target on shares of Definitive Healthcare from $11.00 to $9.50 and set a buy rating on the stock in a research note on Wednesday. Nine equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Definitive Healthcare currently has an average rating of Hold and an average target price of $9.94.

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock traded down $0.18 on Thursday, hitting $5.17. 3,323,524 shares of the company were exchanged, compared to its average volume of 643,916. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20. The company has a 50-day moving average price of $7.70 and a 200 day moving average price of $8.29. The stock has a market capitalization of $608.97 million, a price-to-earnings ratio of -2.86, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. Definitive Healthcare has a 1-year low of $4.38 and a 1-year high of $12.45.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The firm had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. As a group, sell-side analysts predict that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.